The present invention provides novel approaches to determining the pH level of the upper GI tract, esophagus and stomach, as an indicator of proper GI function, nutrient absorption and as a means to gauge the overall health of a patient down to the cellular level. This may be determined, practically, in real time as a means of testing for and monitoring GI function without need for sedation or invasive procedures.

A multi-use testing device is disclosed that is able to test a user fluid or dissolved tissue samples for a medical condition comprising, e.g.: blood related, heart (FABS enzymes); liver and kidney function; gene mutations; COVID-19; and pregnancy status. The testing device is positioned in a bio-fluid chamber configured to store at least one electrolyte or charging fluid to create a conductive path for electrons emitted by an anode electrode and a cathode electrode to generate electricity to recharge the micro battery. The generated electricity is transferred to power the testing device. The reusable testing device further comprises a computing device configured to control the communication between a user electronic computing device and the testing device. The reusable testing device is dipped into a sample in a container and outputs the encrypted test result for wireless transmission to electronic computing devices.

The personality assessment and treatment determination system includes a facial recognition device for imaging a patient's face and receiving demographic and personality information from the patient, and a micro-lab device positioned in communication with the facial recognition device. The micro-lab device includes a body having at least one slot configured for receiving a slide holding the patient's bodily fluid, a scanner for analyzing the patient's bodily fluid, and a selector switch for selecting the bodily fluid to be analyzed. The information from the facial recognition device, each of the plurality of questionnaires, and from the micro-lab device is combined to determine the patient's psychological disorder and a to treatment for the patient's psychological disorder.

Disclosed is a postprandial glucose-measuring device for preventing the development of or reversing T2D. Included are methods for using the device as well as better use for invasive and noninvasive glucose meters. Further disclosed are novel exercise-sensitizing compositions useful for managing blood glucose levels in Type-2 diabetics with minimal risk of hypoglycemia. The disclosed glucose meters allow a user to also measure exercise and meal size—all with relatively instant feedback—more effectively than having to track the complexity posed by labels, glycemic index and calories. Also disclosed is integration of glucose-measuring devices with smartphones and health monitoring technology to make possible safe and effective interpretation of postprandial glucose readings by a patient to control or reverse Type-2 diabetes.

A hybrid analyte test meter includes a processor operatively connected to a memory, measurement signal generator, measurement signal receiver, and short range wireless transceiver. The processor executes firmware instructions in the memory to operate the measurement signal generator to apply electrical signals to a sample deposited on the electrochemical test strip via the port, receive signal measurements from the measurement signal receiver in response to the predetermined sequence of electrical signals, and transmit data corresponding to the plurality of signal measurements to an external computing device using the short range wireless transceiver, wherein the processor does not identify a measurement of an analyte in the sample based on the plurality of signal measurements.

Provided is a sensor unit (104) for detecting an analyte (128) in an aqueous medium. The sensor unit comprises a surface (124) for receiving the aqueous medium thereon. Capture species (126) immobilized on the surface reversibly bind the analyte. A detector (130) detects the analyte when the analyte is bound to the capture species. The sensor unit further comprises an electrolysis assembly (132). The electrolysis assembly comprises a plurality of spatially separated electrically conductive areas (134) on the surface, and a power supply (136) for supplying a voltage across at least two of the electrically conductive areas. The voltage is sufficient to electrolyse the aqueous medium received on the surface. Further provided is a body fluid monitoring device (101) comprising the sensor unit, and a method for detecting an analyte.

An apparatus for insertion of a medical device in the skin of a subject is provided.

Embodiments described herein relate to an analyte monitoring device having a user interface with a display and a plurality of actuators. The display is configured to render a plurality of display screens, including a home screen and an alert screen. The home screen is divided into a plurality of simultaneously displayed panels, with a first panel displays a rate of change of continuously monitored analyte levels in interstitial fluid, a second panel simultaneously displays a current analyte level and an analyte trend indicator, and a third panel displays status information of a plurality of components of the device. When an alarm condition is detected, the display renders the alert screen in place of the home screen, the alert screen displaying information corresponding to the detected alarm condition. Furthermore, the actuators are configured to affect further output of the analyte monitoring device corresponding to the detected condition.

Disclosed is system (100) for determining lifestyle regime for user, the system comprising: user device (102, 204, 300) comprising user agent module, wherein user agent module is configured to generate user interface (302), and receive user input data from user; blood glucose measuring device (104, 202) communicably coupled to user device for operation, blood glucose measuring device comprising electronic strip port for generating electronic signal; temperature sensor for sensing ambient temperature; and control unit configured to compute blood glucose level based on electronic signal and ambient temperature, data aggregating arrangement (106, 208) communicably coupled to user device for receiving blood glucose level and user input data provided by user agent module, and to process blood glucose level and user input data using one or more algorithms to determine lifestyle regime for user and display lifestyle regime on user interface of user device.

Electrochemical test sensors and analysis methods are described that reduce or eliminate the pre-treatment or dilution of blood samples prior to HbA1c analysis. Thus, a blood sample obtained from a blood draw or phlebotomy may be introduced to the electrochemical test sensor for HbA1c analysis. The described test sensors immobilize or deactivate incompatible reagents, enzymes, and antibodies so they do not substantially interfere with each other during the analysis. The test sensors also use heat to catalyze reactions that otherwise would proceed at too slow of a rate to be practical.